Samsung Bioepis Releases its Second US Biosimilar Market Report
Details updated average sales price (ASP) trends and market share across all molecules for which biosimilars are availableIncludes Wholesale Acquisition...
Medicare
New Disease Modifying Drug for Alzheimer’s Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring
Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal...
iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting
Company’s ROI Tool offers preview of business value the ProFound Breast AI Suite offers to clinicians and imaging facilitiesNASHUA, N.H.,...
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
The first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional...
New Report from Inovalon and Harvard Reveals Notable Differences Between Those Opting for Medicare Advantage vs. Traditional Medicare
Collaborative Research Provides Actionable Insights for Payers and Policymakers on Optimizing Plans to Best Meet the Needs of the Rapidly...
ProSomnus Announces Second Quarter 2023 Investor Call and Business Update
PLEASANTON, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of...
PaxMedica Grants Exclusive Pharmacy Distribution Rights for PAX-101 to Vox Nova, LLC
· Agreement for PAX-101 (suramin IV) Distribution in the U.S. for up to 7 years · VoxNova will be responsible...
Alignment Health Welcomes New Chief People Officer as It Scales to Serve More Seniors Nationwide
Seasoned HR executive Melinda Kimbro will drive tech-enabled Medicare Advantage company’s people strategy, ensuring organizational excellence and boosting employee experience...
ReWalk Robotics Ltd. to Host Call to Discuss Medicare Proposal to Establish Personal Exoskeletons Within a Benefit Category for Eligible Beneficiaries
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the...
FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease
Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the...
Privia Health Announces Expansion of and Changes to Board of Directors
Distinguished Healthcare Leader Adam Boehler to Join BoardIncoming CEO Parth Mehrotra to Join BoardWill Sherrill Resigns from BoardARLINGTON, Va,, June...
71% of Self-identified Snorers Have Never Consulted a Healthcare Professional
National survey identifies major obstacles to treating snoring and sleep issuesPLEASANTON, Calif., June 28, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc....
Acentra™ Health Implements Modular, Cloud-based Medicaid Claims System for Utah
MCLEAN, Va., June 22, 2023 (GLOBE NEWSWIRE) -- Utah Medicaid providers have a modern, efficient system for submitting claims following...
Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage
HOUSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering...
BrainsWay Announces Significant Expansion in Western and Central U.S.
30 Deep TMS™ Devices Ordered by Large Mental Health-Focused TMS NetworkBURLINGTON, Mass. and JERUSALEM, June 21, 2023 (GLOBE NEWSWIRE) --...
Relievant Medsystems Announces Favorable Coverage Policy from Cigna Healthcare for the Intracept Procedure
MINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic...
LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has...
Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando
AdventHealth Orlando performs their first implant of Guardian™ System, revolutionizing cardiac care in Central FloridaEATONTOWN, N.J. and ORLANDO, Fla., June...
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
LONDON and SALT LAKE CITY, June 09, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...
Alignment Health Appoints 3 New Executives to Further Drive Strategic Growth Nationally
Todd Macaluso, David Milligan and Joe Kanatzar will be responsible for expanding premier care access for seniors throughout the US...